From Legislation to the Lab: Advancements in Cancer Research (Virtual Event)

Wednesday, November 30, 2022 - 12:00pm to 1:00pmEST

**Pre-Registration is now closed. You may register day-of at acscan.windrosemedia.com**

Fifty-one years after the landmark National Cancer Act was signed into law by President Nixon, public policy continues to play a critical role in advancing biomedical research. From public funding of cancer research to improved access to cutting-edge therapies, state and federal policy have pushed cancer research forward. But gaps remain, inequities persist and opportunities abound. 

Join ACS CAN for a wide-ranging, virtual discussion about the role state and federal policymakers can play in advancing more therapies and, ultimately, more cures. 

Event Speakers & Panelists:

  • Angela B. Freeman, M.S., J.D., Barnes & Thornburg (Moderator) 
  • Kelvin Lee, MD, Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Andrew Mesecar, Ph.D., Purdue University Center for Cancer Research
  • Tabari Baker, Ph.D., Roche Diagnostics
  • Jennifer Pegher, M.A., Association of American Cancer Institutes 

Support ACS CAN

Thank you to our sponsors.
 



BMS Resized.jpeg
Lilly logo
Indiana Oncology Society
Dr. Douglas Kelsey
Hoosiers Work for Health
Gilead Sciences
Janssen Oncology
Genentech
GlaxoSmithKline
Novartis
Pfizer